Association of British HealthTech Industries

Azra AI Launches Groundbreaking Patient Journey Module for Comprehensive Cancer Patient Tracking

Retrieved on: 
Thursday, July 27, 2023
Technology, Other Technology, Health Technology, Software, Other Health, Health, Data Management, Artificial Intelligence, Oncology, Communication, Software as a service, Benefit, Aftercare, Health care, Association of British HealthTech Industries, Cancer, Patient, Electronic health record, St. Elizabeth Healthcare (Kentucky), Hospital, Documentation, EHR, Machine learning, Artificial intelligence, Azra, Inspira Health Network, Medical device, Nursing, AI

Azra AI , a healthtech leader that provides artificial intelligence (AI) and workflow automation tools to accelerate the identification and treatment of cancer, is proud to announce the launch of its groundbreaking Patient Journey module.

Key Points: 
  • Azra AI , a healthtech leader that provides artificial intelligence (AI) and workflow automation tools to accelerate the identification and treatment of cancer, is proud to announce the launch of its groundbreaking Patient Journey module.
  • Key Features and Benefits of the Azra AI Patient Journey Module:
    Centralized Care Management: Using AI, the Patient Journey module consolidates patient information, medical history, and treatment plans into a single, user-friendly interface.
  • Navigation Standardization: The Patient Journey module ensures that navigators no longer have to rely on outdated methods for tracking cancer patient care.
  • “We’re excited to introduce the Patient Journey module, as it represents a significant milestone in our mission to use AI to accelerate cancer treatment,” said Chris Cashwell, CEO of Azra AI.

Silicon Valley Bank Appoints New Leadership to Support Life Science and Healthcare Sector

Retrieved on: 
Thursday, July 27, 2023
Partnership, First Citizens BancShares, Head, Health care, Customer, Association of British HealthTech Industries, Silicon Valley Bank, Research, Silicon, SVB, SAN, Growth, Annual report, Credit Solutions of America, Nursing, Scheffel

SAN FRANCISCO, July 27, 2023 /PRNewswire/ -- Silicon Valley Bank, a division of First Citizens Bank, today announced that 16-year SVB veteran Jackie Spencer has been named the new Head of Relationship Management for Life Science and Healthcare Banking.  The company also announced that 26-year SVB veteran Megan Scheffel was named Head of Credit Solutions for the Life Science and Healthcare practice. Spencer and Scheffel report to 30-year SVB leader Joan Parsons, Head of Technology and Healthcare Banking at Silicon Valley Bank (SVB).

Key Points: 
  • SAN FRANCISCO, July 27, 2023 /PRNewswire/ -- Silicon Valley Bank , a division of First Citizens Bank, today announced that 16-year SVB veteran Jackie Spencer has been named the new Head of Relationship Management for Life Science and Healthcare Banking.
  • The company also announced that 26-year SVB veteran Megan Scheffel was named Head of Credit Solutions for the Life Science and Healthcare practice.
  • Spencer and Scheffel report to 30-year SVB leader Joan Parsons, Head of Technology and Healthcare Banking at Silicon Valley Bank (SVB).
  • Prior to her current role, she was Global Senior Credit Officer for Life Science and Healthcare.

Innovative Solutions Launches Tailwinds on AWS

Retrieved on: 
Wednesday, July 26, 2023
Software as a service, Amazon Web Services, David Prever, API, Fintech, Amazon, Data analysis, Anthropization, Growth, Association of British HealthTech Industries, CIO, AI, Innovative Solutions In Space, Infrastructure as code, SVP, Environment, AWS, Online shopping, Sales, Tailwind CSS, Innovation

ROCHESTER, N.Y. , July 26, 2023 /PRNewswire/ -- Innovative Solutions, a leading provider of cloud services for growing businesses, announced today that it has launched its Tailwinds product on the Amazon Web Services, Inc. (AWS) marketplace. Built by Innovative and based upon technologies from both AWS and Anthropic, Tailwinds allows business leaders and software engineers to use generative AI technology within their applications without the complexity, high cost, and time associated with traditional software development. This new tool enables small to midsize businesses to seamlessly adopt AI technologies in their applications.

Key Points: 
  • ROCHESTER, N.Y. , July 26, 2023 /PRNewswire/ -- Innovative Solutions, a leading provider of cloud services for growing businesses, announced today that it has launched its Tailwinds product on the Amazon Web Services, Inc. (AWS) marketplace.
  • Built by Innovative and based upon technologies from both AWS and Anthropic, Tailwinds allows business leaders and software engineers to use generative AI technology within their applications without the complexity, high cost, and time associated with traditional software development.
  • Innovative announced today that it has launched its Tailwinds product on the Amazon Web Services (AWS) marketplace.
  • "We're proud to introduce Tailwinds to the market," said Travis Rehl, SVP of Product and Service at Innovative Solutions.

First AI as CEO in Europe Revolutionizes Leadership using Human Supervision for Safety

Retrieved on: 
Monday, July 24, 2023
Association of British HealthTech Industries, AI, Human, Weakness, Intelligence, Safety, Customer service, Management

Using a combination of AI and human intelligence, the hybrid system goes beyond just a chatbot, and is based on a new simple mathematical algorithm.

Key Points: 
  • Using a combination of AI and human intelligence, the hybrid system goes beyond just a chatbot, and is based on a new simple mathematical algorithm.
  • Hunna has been testing the IndigoVX AI system for 12 months to ensure safety and legal compliance before announcing its promotion to CEO.
  • "The AI CEO has successfully identified under-explored markets, optimized resource allocation, and accurately forecasted consumer trends, with an over 90% successful decision rate."
  • Successes of the AI to date include:
    Hunna's mission is to harness the power of AI while ensuring safety and accountability through constant human supervision.

First AI as CEO in Europe Revolutionizes Leadership using Human Supervision for Safety

Retrieved on: 
Monday, July 24, 2023
Association of British HealthTech Industries, AI, Human, Weakness, Intelligence, Safety, Customer service, Management

Using a combination of AI and human intelligence, the hybrid system goes beyond just a chatbot, and is based on a new simple mathematical algorithm.

Key Points: 
  • Using a combination of AI and human intelligence, the hybrid system goes beyond just a chatbot, and is based on a new simple mathematical algorithm.
  • Hunna has been testing the IndigoVX AI system for 12 months to ensure safety and legal compliance before announcing its promotion to CEO.
  • "The AI CEO has successfully identified under-explored markets, optimized resource allocation, and accurately forecasted consumer trends, with an over 90% successful decision rate."
  • Successes of the AI to date include:
    Hunna's mission is to harness the power of AI while ensuring safety and accountability through constant human supervision.

Soaak Technologies Awarded Phase I Small Business Innovation Research (SBIR) Contract from the U.S. Air Force

Retrieved on: 
Thursday, July 20, 2023
Transfer, Theta, Metabolic typing, USAF, STTR, SBIR, United States Department of Defense, Association of British HealthTech Industries, Brain mapping, Aircraft, Military personnel, Low-level laser therapy, Acquisition, Patient, Stress, Air force, The, EMDR, Small business, Small Business Innovation Research, United States Department of the Air Force, AFWERX, R, Service, Mental health, Digital electronics, Medical imaging

TULSA, Okla., July 20, 2023 /PRNewswire/ -- Soaak Technologies, Inc., (https://www.soaak.com/), a healthtech company known for their clinically proven sound frequency composition therapies, has been awarded a Phase I Small Business Innovation Research (SBIR) contract from the U.S. Air Force (USAF) for 2023.

Key Points: 
  • Advanced Digital Technologies Leader Provides Dynamic New Solutions To U.S. Air Force Through Sound Frequency Composition Therapies
    TULSA, Okla., July 20, 2023 /PRNewswire/ -- Soaak Technologies, Inc., ( https://www.soaak.com/ ), a healthtech company known for their clinically proven sound frequency composition therapies, has been awarded a Phase I Small Business Innovation Research (SBIR) contract from the U.S. Air Force (USAF) for 2023.
  • The Air Force Office of Small Business Programs utilizes the Department of Defense (DoD) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs to harness the talents of our nation's emerging technology companies.
  • These programs stimulate technological innovation and accelerate development and production of promising technologies that can help the Air Force accomplish its mission.
  • "We are honored to be awarded this Phase I contract with the U.S. Air Force," states Henry Penix, Executive Chairman of Soaak Technologies.

SayHeart: The AI Powerhouse Decoding Health Complexity

Retrieved on: 
Thursday, July 20, 2023
Generative, Biotechnology, Association of British HealthTech Industries, MVP, Amazon Web Services, Emergency medicine, Marketing, Medical device

Employing Generative AI, SayHeart has devised an algorithm that seamlessly translates medical jargon, health reports, and complex imaging into visual, easily digestible content.

Key Points: 
  • Employing Generative AI, SayHeart has devised an algorithm that seamlessly translates medical jargon, health reports, and complex imaging into visual, easily digestible content.
  • This ground-breaking technology aims to democratize health information, empower individuals, and unburden healthcare professionals from administrative load.
  • Post-launch, the team has set sights on conducting comprehensive studies in Malaysia and Singapore, utilizing local community health report data for refining their technology.
  • SayHeart's unique offering includes advanced text-to-visual translation, differential diagnosis, and predictive features for various health conditions, all bundled in a user-friendly package.

United Renewables CEO Chris Caldwell Explores Climate Venture Capital and the Sustainability Revolution

Retrieved on: 
Thursday, July 20, 2023
Isle, Attitude, Learning, Venture capital, Association of British HealthTech Industries, Fintech, Conservative Party, Climate, VC, Renewable energy

DOUGLAS, Isle of Man, July 20, 2023 (GLOBE NEWSWIRE) -- As the sustainability revolution sweeps through most industries in the West, the climate venture capital space is now in the spotlight. Amidst the excitement, questions arise about how the climate old guard is embracing newcomers. Christopher Caldwell, CEO of United Renewables, entrepreneur, and host of Conversations on Climate podcast, offers valuable insights on the changing landscape.

Key Points: 
  • Christopher Caldwell, CEO of United Renewables, entrepreneur, and host of Conversations on Climate podcast, offers valuable insights on the changing landscape.
  • Investors are awakening to the potential of the next trillion-dollar market, turning climate venture capital into the height of fashion.
  • Mentorship and guidance will prevent repeating past mistakes and will lead to a sustainable, thriving climate venture capital ecosystem.
  • To explore the full conversation on the sustainability revolution and the evolving climate Venture Capital landscape, tune in to the Conversations on Climate podcast episode with Amory Poulden .

Enspectra Health's Initiative to Advance Predictive Algorithms for Skin Precancers Awarded $2M Grant from the NIH.

Retrieved on: 
Wednesday, July 19, 2023
Database, Aks, SCC, Biopsy, SBIR, Deep learning, Association of British HealthTech Industries, Skin cancer, Pathology, Skin, Research, Bangladesh Technical Education Board, Small Business Innovation Research, National Cancer Institute, Conditional sentence, Direct, Patient, Carcinoma, Algorithm, Melanoma, NCI, Pharmaceutical industry, Medical imaging

MOUNTAIN VIEW, Calif., July 19, 2023 /PRNewswire/ -- Enspectra Health, a healthtech company pioneering the virtual biopsy, has been awarded $2M in grant funding from the National Cancer Institute (NCI), part of the National Institutes of Health, through the Small Business Innovation Research (SBIR) Program. The funding will support research for developing deep learning algorithms to predict which precancerous lesions, Actinic Keratosis (AK), are likely to progress to squamous cell carcinoma (SCC), a form of non-melanoma skin cancer. AKs affect more than 58 million Americans1 and can progress to SCC, which kills more Americans than melanoma each year.2 The annual cost of treating non-melanoma skin cancers in the U.S. is estimated to be $4.8 billion.

Key Points: 
  • Unlike slide based scanners that require biopsies for digitization, Enspectra's technology digitizes pathology instantaneously and directly from a subject's skin in vivo.
  • With the NCI grant, Enspectra will build a large database of digital histopathology on patients with AKs before topical therapy is applied.
  • "We are thrilled to have been awarded a Direct-to-Phase II SBIR grant from the NCI to support the development of predictive algorithms for skin precancers," said Gabriel Sanchez, Ph.D., CEO and co-founder of Enspectra Health.
  • "This grant will accelerate our vision to noninvasively detect and monitor skin conditions earlier to advance care for the millions of patients with skin conditions."

OrganOx Raises £25 Million in Growth Round Led by Lauxera Capital Partners

Retrieved on: 
Monday, July 17, 2023
Surgeon, Liver transplantation, Transplant, MD, Patient, NMP, Growth, Association of British HealthTech Industries, R, Metra, Dentistry

The proceeds from the fundraise will enable OrganOx to significantly expand its commercial footprint across strategically key areas of the business.

Key Points: 
  • The proceeds from the fundraise will enable OrganOx to significantly expand its commercial footprint across strategically key areas of the business.
  • This includes expanding the customer-facing team in the United States due to high interest and adoption of the OrganOx technology.
  • Sam Levy, MD, Lauxera Capital Partners, added: “Lauxera is proud and honoured to back the OrganOx team and its global commercial scale-up.
  • This is the ninth investment made by Lauxera Growth I, a growth buy-out fund dedicated to investing in commercial-stage European and North American HealthTech businesses.”
    Craig Marshall, Chief Executive Officer, OrganOx said: “We are thrilled to have Lauxera Capital Partners at the table.